Lenabasum Improved Skin Symptoms, in Small Dermatomyositis Trial
In the phase 2 trial, skin biopsies before and after treatment showed significant reductions in inflammatory cytokines relevant to dermatomyositis pathogenesis.
New York United States University Of Pennsylvania Hospital For Special Surgery Robert Spiera European Congress
Source: medscape.com